Wenn Sie allgemeine Fragen haben, wenden Sie sich bitte an unseren Kundenservice:
Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Telefon: +49 6151 72-0
Fax: +49 6151 72 2000
15 Februar 2012
wird geladen
Mixture of cytotoxic glycopeptides that inhibits DNA synthesis by reacting with DNA and causing strand scission. Acts by generating hydroxyl free radicals which cleave N-glycosidic bonds and cause base elimination (mainly T) and phosphodiester bond scission. An anti-neoplastic agent. Bleomycin has been used in the treatment of squamous cell carcinomas, testicular tumors, and malignant lymphomas.
| Produktinformationen | |||
|---|---|---|---|
| Form | White to off-white solid | ||
| Hygrocopic | Ja | ||
| Biological activity | Potency: 1.5-2.0 U/mg | ||
| Purity | ≥90% by HPLC (A2 + B2) | ||
| RTECS | EC5991990 | ||
| CAS-Nummer | 9041-93-4 | ||
| Merck USA index | 14, 1318 | ||
| Lager- und Versandinformationen | |||
|---|---|---|---|
| Lagerkategorie | +2°C to +8°C | ||
| Ship |
Ambient Temperature Only
Harmful & Carcinogenic / Teratogenic |
||
| Sicherheitshinweise | |||
|---|---|---|---|
| S-Satz |
S: 22-26-36/37/39-45 |
||
| R-Satz |
R: 20/21/22-36/37/38-40-42/43 |
||
